STATUTORY MANDATE // RISK STATEMENT 2026

Risk Disclosure Statement

Effective Date: January 15, 2026. Last Updated: February 18, 2026.

1. General Speculative Nature of Financial Markets

This Risk Disclosure Statement is issued by Assay Cambistorine to inform prospective and active users of the substantial risks inherent in participating in spot digital token markets, decentralized derivatives, foreign exchange instruments, and automated algorithmic strategies. Prior to interacting with our computational tools, you must carefully evaluate your investment objectives, technical knowledge, risk tolerance, and personal financial position.

2. Extreme Volatility and Price Disruption

Cryptocurrency prices fluctuate dramatically over compressed time intervals. Price swings may be triggered by macroeconomic announcements, shifting regulatory policies across primary jurisdictions, liquidity imbalances, social sentiment shifts, or sudden market interventions. Digital assets can experience rapid declines of 50% or more within hours. Such volatility can trigger liquidation events, automatic margin calls, or total loss of committed capital.

3. Algorithmic and Machine-Learning Limitations

While Assay Cambistorine integrates advanced predictive algorithms, artificial intelligence parsing, and microsecond data evaluation, algorithmic systems possess inherent limitations:

• Historical Simulation Bias: Backtested metrics, historical win rates, and simulation calculators displayed across the Platform reflect mathematical simulations under past conditions. They do not constitute guaranteed predictors of future market behavior;
• Systemic Parameter Breakdown: Extraordinary market conditions, black-swan shocks, flash crashes, and anomalous trading behaviors may cause quantitative models to generate suboptimal or adverse execution signals;
• Unintended Executions: Automated triggers operate strictly on algorithmic logic and may execute transactions during adverse spreads or fragmented liquidity conditions.

4. Execution Latency, Slippage, and Liquidity Deficits

Market orders and algorithmic signals may suffer execution slippage. Slippage occurs when an order fills at a price different from the expected quotation, frequently during times of extreme momentum, low market depth, or order book gap events. Neither Assay Cambistorine nor connected liquidity hubs guarantee that limit or stop-loss orders will execute at designated prices without slippage.

5. Network, Protocol, and Technology Risks

Engaging with digital token protocols entails distinct technical risks outside the operational sphere of Assay Cambistorine:

• Blockchain network congestion leading to delayed confirmations or stranded transactions;
• Sudden consensus divergence, chain reorganizations, or unannounced hard forks;
• Smart contract bugs, compiler vulnerabilities, or protocol exploits in underlying decentralized tokens;
• Client-side internet service failures, hardware latency, and API credential compromise.

6. Regulatory, Legal, and Tax Uncertainty

The regulatory architecture surrounding digital assets, automated trade signaling, and decentralized assets is subject to active revision globally and within the Republic of Singapore. Future statutory enactments, supervisory policies from financial authorities, or sudden legal prohibitions may severely restrict the utility, convertibility, or transferability of digital assets without notice. Users remain exclusively responsible for assessing and satisfying all tax reporting liabilities arising from their transactions.

7. No Fiduciary or Investment Advisory Relationship

Assay Cambistorine operates exclusively as a financial technology platform provider. The Company does not offer bespoke investment advice, portfolio management, or fiduciary wealth stewardship. No communication from the Company, whether published on the Platform or provided via direct support channels, should be construed as an invitation, solicitation, or recommendation to acquire, hold, or sell any particular digital token or financial asset.

8. User Capital Acknowledgement

By using Assay Cambistorine, you expressly confirm, acknowledge, and agree that:

• You have read and comprehensively understood every risk factor outlined in this disclosure;
• You retain sole, undivided responsibility for your financial decisions and algorithmic configurations;
• You accept that Assay Cambistorine cannot and does not guarantee investment returns, capital preservation, or risk-free operation under any market circumstances.

9. Questions and Risk Inquiries

If you require clarification regarding any aspect of this Risk Disclosure Statement, you are encouraged to consult an independent, licensed financial advisor or reach out to our team at [email protected].